SEQIRUS

Manufacturing Influenza vaccines

25 Deforest Ave Suite 200 Summit NJ 07901, Summit, NJ  ·  JAMES SHERNER

Filings
45
Clients
1
Total Income
Years Active
2016–2026

Filings

Year Client Period Income Expenses Doc
2026 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$280,000
2025 SEQIRUS 3rd Quarter (July 1 - Sep 30)
AMENDED
$400,000
2025 SEQIRUS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$250,000
2025 SEQIRUS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$250,000
2025 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$260,000
2025 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$250,000
2024 SEQIRUS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$220,000
2024 SEQIRUS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$370,000
2024 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$200,000
2024 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$220,000
Page 1 of 5  ·  45 filings Next

Clients Represented

ClientFilingsTotal Income
SEQIRUS 45

Lobbyists

NameDisclosed Prior Position
CHRISTINE FARQUHARSON OMB, Health Division, Program Examiner (2010-2021)
PHYLLIS FROSST